HIV disease treatment in the era of HAART
P Bonfanti, A Capetti, G Rizzardini - Biomedicine & pharmacotherapy, 1999 - Elsevier
In the last three years basic science and clinical research have radically changed the
therapeutical approach to HIV disease. Recent guidelines suggest that treatments to HIV …
therapeutical approach to HIV disease. Recent guidelines suggest that treatments to HIV …
History of HAART–the true story of how effective multi-drug therapy was developed for treatment of HIV disease
M Delaney - Retrovirology, 2006 - Springer
The development of multi-drug combination therapy for treatment of HIV disease is
considered one of the great success stories of modern medicine. In a period of …
considered one of the great success stories of modern medicine. In a period of …
Current status and future issues in the treatment of HIV-1 infection.
S Matsushita - International journal of hematology, 2000 - europepmc.org
Over the past 5 years, advances in human immunodeficiency virus type 1 (HIV-1) clinical
research and data on the effectiveness of potent combination therapy have substantially …
research and data on the effectiveness of potent combination therapy have substantially …
Limits to potent antiretroviral therapy
A Telenti, G Paolo Rizzardi - Reviews in medical virology, 2000 - Wiley Online Library
The availability of potent combination antiretroviral therapy (ART), also known as highly
active antiretroviral therapy or HAART has changed the prognosis of HIV infection. However …
active antiretroviral therapy or HAART has changed the prognosis of HIV infection. However …
[PDF][PDF] Modern anti-HIV therapy
M Flepp, V Schiffer - Swiss Medical Weekly, 2001 - smw.ch
Ten principles governing anti-retroviral treatment are summarised in Table 1. Starting and
maintaining HAART is complex. Within the last few years, the numbers of antiretrovirals, their …
maintaining HAART is complex. Within the last few years, the numbers of antiretrovirals, their …
HAART in HIV/AIDS treatments: future trends
DY Lu, HY Wu, NS Yarla, B Xu… - … Disorders-Drug Targets …, 2018 - ingentaconnect.com
AIDS (acquired immune deficient syndrome) is a deadly human viral infectious disease
caused by HIV (human immune-deficient virus) infection. Almost every AIDS patient losses …
caused by HIV (human immune-deficient virus) infection. Almost every AIDS patient losses …
HIV-1 and HAART: a time to cure, a time to kill
MS Saag, JM Kilby - Nature medicine, 1999 - nature.com
HIV-1 and HAART: A time to cure, a time to kill | Nature Medicine Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …
you for visiting nature.com. You are using a browser version with limited support for CSS. To …
New antiretroviral drugs and approaches to HIV treatment
R Paredes, B Clotet - Aids, 2003 - journals.lww.com
The favorable impact of highly active antiretroviral therapy (HAART) on morbidity and
mortality of HIV-infected patients [1, 2] is constrained by the limited durability of the efficacy …
mortality of HIV-infected patients [1, 2] is constrained by the limited durability of the efficacy …
Achieving a cure for HIV infection: do we have reasons to be optimistic?
V Le Douce, A Janossy, H Hallay, S Ali… - Journal of …, 2012 - academic.oup.com
The introduction of highly active antiretroviral therapy (HAART) in 1996 has transformed a
lethal disease to a chronic pathology with a dramatic decrease in mortality and morbidity of …
lethal disease to a chronic pathology with a dramatic decrease in mortality and morbidity of …
Highly active antiretroviral therapy for treatment of HIV/AIDS patients: current status and future prospects and the Indian scenario
G Kumari, RK Singh - HIV & AIDS Review, 2012 - Elsevier
As the menace of HIV/AIDS continues to rise, effective drug treatments are required to reach
the infected masses. HAART provides durable control of virus replication, however, it is not …
the infected masses. HAART provides durable control of virus replication, however, it is not …